The dilemma of routine testing for calcitonin thyroid nodule’s patients to detect or exclude medullary carcinoma: one single negative test should be valuable as rule-out strategy to avoid further calcitonin measurements over time

PURPOSE: While calcitonin (CT) measurement is recognized as the most accurate tool to diagnose medullary thyroid carcinoma (MTC), its routine use in patients with thyroid nodule (TN) is not universally accepted. The present study raised the question whether a TN patient with an initial normal CT can...

Descripción completa

Detalles Bibliográficos
Autores principales: Trimboli, Pierpaolo, Camponovo, Chiara, Ruinelli, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242962/
https://www.ncbi.nlm.nih.gov/pubmed/35391593
http://dx.doi.org/10.1007/s12020-022-03047-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242962/
https://www.ncbi.nlm.nih.gov/pubmed/35391593
http://dx.doi.org/10.1007/s12020-022-03047-2

Ejemplares similares